乳酸乳球菌来源的反式唾液酸酶抗原联合c-di-AMP经鼻免疫可预防急性口服克氏锥虫感染
本研究比较两种以反式唾液酸酶(TS)为基础的黏膜疫苗经鼻免疫BALB/c小鼠的免疫原性和预防效果。TS+ISPA与TS+c-di-AMP均诱导明显的全身体液和细胞免疫应答,但仅TS+c-di-AMP组控制寄生虫血症,并显著减少组织寄生虫负荷、临床表现和组织损伤。TS+c-di-AMP诱导中和血浆抗体和黏膜IgA增强,作者认为该制剂是预防克氏锥虫感染的有前景策略。
要点
- TS+c-di-AMP经鼻免疫诱导全身IgG2a应答和黏膜分泌型IgA增强。
- 仅TS+c-di-AMP组在口服克氏锥虫攻击后控制寄生虫血症。
- TS+c-di-AMP组急性期组织寄生虫负荷、临床表现和组织损伤显著减少。
核心结论
- TS+c-di-AMP经鼻免疫制剂表现出较好的预防克氏锥虫感染能力,作者认为其是预防克氏锥虫感染的有前景策略。
研究设计与样本
- 研究用BALB/c小鼠经鼻免疫3剂(每两周1剂),比较TS+ISPA、TS+c-di-AMP、单用TS和生理盐水对照组的免疫原性与预防效果。
主要发现
- 末次免疫后15天,TS+ISPA和TS+c-di-AMP均诱导明显的全身体液和细胞应答,表现为血浆抗TS IgG2a滴度和IgG2a/IgG1比值升高及针对TS的细胞应答增强。
- TS+c-di-AMP组血浆抗体可在体外抑制克氏锥虫入侵能力,且特异性分泌型IgA增强更明显。
- 口服克氏锥虫攻击后,仅TS+c-di-AMP组实现寄生虫血症控制,尽管所有疫苗组均显示CD8+IFN-γ+ T细胞数量增加。
- 急性期TS+c-di-AMP组组织寄生虫负荷、临床表现和组织损伤显著减少。
- TS+ISPA与TS+c-di-AMP组免疫原性和CD8+IFN-γ+ T细胞应答相似,TS+c-di-AMP较好的预防能力与诱导中和血浆抗体和黏膜IgA水平升高相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The new generation of vaccines for Chagas disease, are focused to induce both humoral and cellular response to effectively control Trypanosoma cruzi parasites. The administration of vaccine formulations intranasally has the advantage over parenteral routes that can induce a specific response at mucosal and systemic levels. This study aimed to evaluate and compare the immunogenicity and prophylactic effectiveness of two Trans-sialidase (TS)-based mucosal vaccines against T. cruzi administered intranasally. Vaccines consisted of a recombinant fragment of TS expressed in Lactococcus lactis formulated in two different adjuvants. The first, was an immunostimulant particle (ISPA, an ISCOMATRIX-like adjuvant), while the second was the dinucleotide c-di-AMP, which have shown immunostimulant properties at the mucosal level. BALB/c mice were immunized intranasally (3 doses, one every two weeks) with each formulation (TS + ISPA or TS + c-di-AMP) and with TS alone or vehicle (saline solution) as controls. Fifteen days after the last immunization, both TS + ISPA or TS + c-di-AMP induced an evident systemic humoral and cellular response, as judged by the increased plasma anti-TS IgG2a titers and IgG2a/IgG1 ratio and enhanced cellular response against TS. Plasma derived antibodies from TS + c-di-AMP also inhibit in vitro the invasion capacity of T. cruzi. Furthermore, specific secretory IgA was more enhanced in TS + c-di-AMP group. Protective efficacy was proved in vaccinated animals by an oral T. cruzi-challenge. Parasitemia control was only achieved by animals vaccinated with TS + c-di-AMP, despite all vaccinates groups showed enhanced CD8+IFN-γ+ T cell numbers. In addition, it was reflected during the acute phase in a significant reduction of tissue parasite load, clinical manifestations and diminished tissue damage. The better prophylactic capacity elicited by TS + c-di-AMP was related to the induction of neutralizing plasma antibodies and augmented levels of mucosal IgA since TS + ISPA and TS + c-di-AMP groups displayed similar immunogenicity and CD8+IFN-γ+ T-cell response. Therefore, TS + c-di-AMP formulation appears as a promising strategy for prophylaxis against T. cruzi.
引用
- Pacini MF, González FB, Dinatale B, et al. Nasal immunization with a L. lactis-derived trans-sialidase antigen plus c-di-AMP protects against acute oral T. cruzi infection. Vaccine. 2022. PMID: 35279330. doi:10.1016/j.vaccine.2022.02.071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。